Understanding angiogenic function in normal term pregnancies
Official title: Angiogenic Function at Normal Term on Placenta
Run by Centre Hospitalier Intercommunal Creteil · NCT03981653 · Data updated 2026-11-12
This study looks at how certain cells in healthy pregnancies help with blood vessel growth in the placenta to see if it can lead to better treatments for pregnancy problems like pre-eclampsia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 750 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 1 site (Créteil) |
| Status | Recruiting |
| Started | March 20, 2019 |
| Main results expected | March 2029 |
| Study ends | March 2029 |
| Registry record updated | December 21, 2022 |
| Trial ID | NCT03981653 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women with strictly normal pregnancies or those with specific complications like gestational diabetes or pregnancy cholestasis, who are scheduled for cesarean delivery after 37 weeks.
✕Probably not a fit
Patients with multiple pregnancies, known major fetal malformations, or those experiencing pre-eclampsia or intrauterine growth restriction will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the angiogenic function of trophoblasts in placentas from healthy pregnancies at term. It aims to analyze the expression of pro- and antiangiogenic factors, such as placenta growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1), in human differentiated trophoblastic cells. The study will also explore the effects of various chemical compounds on placental functions and trophoblastic differentiation, potentially identifying therapeutic targets for pregnancy-related pathologies like pre-eclampsia and intrauterine growth restriction. By measuring gene and protein expression variations, the research seeks to enhance understanding of placental pathophysiology.
Why it matters
Potential benefit: If successful, this study could lead to new therapeutic strategies for managing pregnancy complications related to placental dysfunction.
How similar studies have gone: While this study explores a specific aspect of placental function, similar studies have shown promise in understanding angiogenic factors in pregnancy-related conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnancies with scheduled cesarean delivery \>37 weeks of amenorrhea: * strictly normal pregnancies * complicated pregnancies of gestational diabetes, insulin-treated or not * complicated pregnancies due to pregnancy cholestasis * spontaneous or in vitro fecondation (IVF) / Intracytoplasmic sperm injection (ICSI) pregnancies with or without oocyte donation Exclusion Criteria: * Patient's opposition * Age \< 18 years old * Women under the protection of justice * Multiple pregnancy * Known major fetal malformation * Pre-eclampsia and intrauterine growth retardation * Placental insertionnomaly * Type 1 diabetes * HIV-positive patient with HIV/hepatisis C virus (HCV) regardless of viral load * Patient in labour at the time of Caesarean section * Patient whose medical history results in medication being taken in pregnancy courses that may interfere with the biology of the trophoblast (immunomodulators in case of autoimmune diseases, anti-rejection drugs in case of transplant patients)
Where it's running
-
Centre Hospitalier Intercommunal de Créteil
Créteil, France Recruiting
Study contacts
- Study coordinator: camille JUNG, MD
- Email: camille.jung@chicreteil.fr
- Phone: 00157022268
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Lower-extremity blood pressure monitoring during cesarean under spinal anesthesia
This study tests whether noninvasive blood pressure monitoring from the toe is better than the arm at predicting neonatal outcomes during cesarean delivery with spinal anesthesia.
-
Care4mommies: a compassion-based approach to support moms-to-be
A compassion-based program with pregnancy-specific content is being tested to see if it helps pregnant people build self-compassion and strengthen the bond with their baby.
-
Eating more eggs during pregnancy to support fetal brain development
This test will see if pregnant women who eat 10–14 eggs per week have better fetal brain development than those who follow a general healthy prenatal diet.
-
See if extra prenatal breastfeeding education helps moms in Inland Empire breastfeed exclusively
This study tests whether supplemental breastfeeding education during pregnancy increases exclusive breastfeeding at 6 weeks after birth for first-time moms or those who didn’t breastfeed long in the past.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.